Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse

Bone Marrow Transplantation, Published online: 25 April 2023; doi:10.1038/s41409-023-01987-5Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse

Source: Bone Marrow Transplantation - April 25, 2023 Category: Hematology Authors: Andrew Kent Marc Schwartz Christine McMahon Maria Amaya Clayton A. Smith Jennifer Tobin Kelsey Marciano Rebecca Rezac Grace Bosma Daniel A. Pollyea Jonathan A. Gutman Source Type: research